A dejected Woodruff saw his start come to an end after throwing four straight changeups between 73 and 75 mph in the fourth.

Intel faces asymmetric downside risk as AI infrastructure efficiency may outpace monetized demand, risking valuation ...

After a half-season of strict platoons and few changes to the top of the lineup, the Mets are finally showing a willingness ...

The top two contenders in the American League Central meet for a four-game series at Progressive Field. Follow along here for ...

Hadley Kelly, a rising senior at Mobile Christian School in Mobile, was named the AL.com Coastal Alabama Female Athlete of the Year earlier this week. She was a force on the Leopards’ basketball team, ...

Max Muncy has put together an impressive all-around first half. His .871 OPS through Thursday leads NL third basemen. But ...

With the 2026 MLB draft just around the corner, it's a perfect time for a redraft -- but why stop at picking prospects from one past class? We combined the loaded 2023, 2024 and 2025 drafts into one ...

Paul Hoynes and Joe Noga break down Brayan Rocchio's impact, David Fry's pinch-hit heroics and Daniel Espino's encouraging outing.

Travere Therapeutics has transitioned into a rare disease commercial platform, driven by FILSPARI’s growth in IgAN and recent FSGS approval. More on TVTX stock.

Daniel Schneemann is truly a man for all positions. The Guardians’ utility man says he doesn’t have a favorite position even ...

The Seattle Mariners must avoid a passive 2026 MLB trade deadline and add a real offensive upgrade to take control of the AL ...